Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
A new study published in the JAMA Psychiatry gives the strongest evidence that semaglutide — the active ingredient in Ozempic ...
Semaglutide, the active ingredient in both Ozempic and Wegovy, could be a possible treatment for alcohol abuse.
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.